tiprankstipranks
Innovent Biologics (MX:1801N)
:1801N
Mexico Market
1801N
Innovent Biologics
RESEARCH TOOLSreports

Innovent Biologics (1801N) Balance Sheet

1 Followers

Innovent Biologics Balance Sheet

Innovent Biologics's total assets for Q2 2026 were ¥41.61B, an increase of 11.36% from the previous quarter. MX:1801N total liabilities were ¥20.06B for the fiscal quarter, a 16.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
¥ 37.36B¥ 21.60B¥ 20.63B¥ 17.59B¥ 16.24B
Total Liabilities
¥ 17.20B¥ 8.48B¥ 8.10B¥ 6.86B¥ 5.91B
Total Equity Gross Minority
¥ 19.36B¥ 13.12B¥ 12.53B¥ 10.73B¥ 10.33B
Other Metrics
Currency in CNY

Innovent Biologics Debt to Assets